We developed and implemented a national surveillance system to monitor and reduce the levels of toxic chemicals in tobacco smoke. A developmental Healthy People 2010 (HP 2010) objective was revised to report on levels of three categories of chemicals—tobacco-specific nitrosamines, polyaromatic hydrocarbons, and volatile organic compounds—in the smoke of leading U.S. cigarette brands. Unit-based sales-weighted average levels were calculated for each chemical category. The target for the new HP 2010 objective is a 10% reduction in unit-based sales-weighted average levels of each chemical category. The Centers for Disease Control and Prevention provided the baseline, target data, and laboratory analyses.
A national data source, national baseline data, and target were presented to the Healthy People Steering Committee during 2005 Midcourse Review. Approval of the revised objective initiated the surveillance of three major classes of toxic chemicals in cigarette smoke. The approved objective provides a feasible, innovative approach for monitoring and supporting measurable population-based reductions in levels of toxic and carcinogenic chemicals in tobacco smoke.
References
1.
Department of Health and Human Services (US). The health consequences of smoking: A report of the Surgeon General. Washington: DHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
Department of Health and Human Services (US). The health consequences of involuntary exposure to tobacco smoke: A report of the Surgeon General. Washington: DHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
4.
International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon (France): IARC; 2004.
Centers for Disease Control and Prevention (US). Exposure to tobacco smoke and harmful substances in tobacco [cited 2006 Jun 29]. Available from: URL: http://www.cdc.gov/nceh/dls/tobacco.htm.
7.
AdamsJDLeeSJVinchkoskiNCastonguayAHoffmannD.On the formation of the tobacco-specific carcinogen 4-(methylnitro-samino)-1-(3-pyridyl)-1-butanone during smoking. Cancer Lett1983;17:339–46.
8.
HoffmannDBrunnemannKDProkopczykBDjordjevicMV. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: Chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health1994;41:1–52.
9.
HechtSS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol1998;11:559–603.
10.
EvansWHThomasNCBoardmanMCNashSJ. Relationship of polycyclic aromatic hydrocarbon yields with particulate matter (water and nicotine free) yields in mainstream and sidestream cigarette smoke. Sci Total Environ1993;136:101–9.
11.
TomkinsBAJenkinsRAGriestWHReaganRRHolladaySK. Liquid chromatographic determination of benzo[a]pyrene in total particulate matter of cigarette smoke. J Assoc Off Anal Chem1985;68:935–40.
12.
International Agency for Research on Cancer. Polynuclear aromatic compounds. part I. chemical, environmental and experimental data. IARC Monographs, Vol. 32. Lyon (France): IARC; 1983.
13.
HoffmannDHechtSSSchmeltzIWynderEL. Polynuclear aromatic hydrocarbons: Occurrence, formation, and carcinogenicity. Structural correlates of carcinogenesis and mutagenesis. A guide to testing priorities. Proceedings of the second FDA Office of Science Summer Symposium;1977 Aug 31-Sep 2; HEW Pub no. FDA-78-1046. p. 120–8.
14.
RubinH.Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: A bio-historical perspective with updates. Carcinogenesis2001;22:1903–30.
15.
HechtSS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst1999;91:1194–210.
16.
HoffmannDHoffmannI.The changing cigarette, 1950–1995. J Toxicol Environ Health1997;50:307–64.
17.
Agency for Toxic Substances and Disease Registry (US). ToxFAQs™ for 2-Butanone. 1995 [cited 2006 Jul 3]. Available from: URL: http://www.atsdr.cdc.gov/tfacts29.html.
18.
Agency for Toxic Substances and Disease Registry (US). ToxFAQs for Benzene. 2005 [cited 2006 Jul 3]. Available from: URL: http://www.atsdr.cdc.gov/tfacts3.html.
19.
Department of Health and Human Services (US). Reducing tobacco use: A report of the Surgeon General. Washington: DHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2000.
20.
Institute of Medicine. Clearing the smoke: The science base for tobacco harm reduction. Washington: Institute of Medicine/National Academy Press; 2001.
21.
National Cancer Institute. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Smoking and Tobacco Control Monograph No.13. Bethesda (MD): Department of Health and Human Services (US), National Institutes of Health, National Cancer Institute;2001.
22.
WynderELMuscatJE. The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect1995;103Suppl 8:143–8.
23.
ThunMJLallyCAFlanneryJTCalleEEFlandersWDHeathCWJr., Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst1997;89:1580–6.
24.
DjordjevicMVStellmanSDZangE.Doses of nicotine and lung carcinogens delivered to cigarette smokers. J Natl Cancer Inst2000;92:106–11.
